During recent years increasing importance has been attached to the study of adrenal cortical hormones, and consequently much work has been directed towards utilizing the daily output of these hormones and their metabolites in urine as an index of adrenocortical function. Hydrolysis of the conjugated forms in which the steroids are present in urine is a necessary preliminary to their extraction and estimation, but the two common methods of hydrolysis by mineral acid and by P-glucuronidase are not entirely satisfactory, the former causing destruction or alteration of a large proportion of the cortical steroids, the latter not being sufficiently quantitative (Bayliss, 1952) .
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Norymberski and his colleagues (Brooks and Norymberski, 1953; Norymberski, Stubbs, and West, 1953) have obviated the difficulties of hydrolysis by a technique in which the side chain on C(17) is oxidized to a ketone group before hydrolysis, the more stable 17-ketosteroids thus formed being hydrolysed by acid and estimated by one of the established methods. As far as is known, all the important cortical steroids containing a hydroxyl group at C(17), with the exception of 17-hydroxy-20-oxosteroids unsubstituted at C'21), are estimated by this means. It seems probable that this group of steroids, the 17-ketogenic steroids, gives a measurement of the adrenal function concerned with the production of 17 ahydroxycorticosterone (hydrocortisone, Kendall's compound F) which has been shown by Bush and Sandberg (1953) to the age of 15 years, after which the males rise to a higher average than the females. Between the ages of 20 and 40 years the male geometric mean, 12.0 mg./day, is significantly higher than the female geometric mean, 9.3 mg./day (P=0.05), results in broad agreement with those of Diczfalusy, Plantin, Birke, and Westman (1955) and of Schuller (1956) . At any age the values for either sex seem to be better represented by a lognormal distribution than by a normal one and for this reason the geometric means are given. In later life the excretion of 17-ketogenic steroids in the men appears to decline. The values for the women do not show a similar decline. The limits drawn on the figures include approximately 80% of the observations to the exclusion of the highest 10% and the lowest 10%. These limits suggest a difference between the two sexes in the relationship of age to rate of excretion. There seems no reason to doubt the validity of the indicated trends in childhood, but in adult life the relatively small number of points in any age group makes the limits tentative; in particular it must be emphasized that in the females a regression with age is not excluded by these observations and, in fact, Schuller (1956) found such a regression.
The limits give what at present appears to be the most convenient representation of the normal range and are intended to facilitate comparison with values found in pathological conditions. Two normal persons on whom 17-ketogenic steroids were assayed on six consecutive days gave values in mg./day of 6.6, 10.4, 7.6, 7.3, 6.4, and 9.1 in one case, and 8. 6, 8.4, 8.8, 7.8, 5.0, and 4.7 in the other.
The 17-ketogenic steroid excretion of two normal women has been assayed throughout the menstrual cycle ; neither case showed any cyclic variation.
In Addison's Disease.-Of 11 cases in which Addison's disease was suspected, six had values for 17-ketosteroids and 17-ketogenic steroids within the normal ranges, and five had low values.
In eight of the cases, the effect of corticotrophin administration on the excretion of both groups of steroids was measured. Table I shows that five cases (D, E, F, G, and H) gave a positive response, and were shown subsequently not to be cases of Addison's disease. The other three cases showed no response.
The results found in patients E and H show the advantage of the 17-ketogenic steroid assay over that of 17-ketosteroids as an indication of response to corticotrophin stimulation; the 17-ketogenic steroids rise from 17 and 6 mg. / day to 53 and 15 mg./day respectively, whereas the 17-ketosteroids rise only from 5 and 7 to 9 and 10 mg./day respectively, changes which without additional evidence might be ascribed to chance day-to-day variation.
This small response of the 17-ketosteroid excretion to corticotrophin stimulation agrees with the findings of Hernberg and Lamberg (1955) .
In Myxoedema and Hypopituitarism.-Statland and Lerman (1950) and Hill, Reiss, Forsham, and Thorn (1950) showed that adrenal cortical function is often depressed in cases of myxoedema, and that thyroid extract therapy usually increased the urinary excretion of 17-ketosteroids. Hubble (1955) showed that the excretion of 17-ketogenic steroids behaves similarly, but the increase is more marked.
In the cases of hypopituitarism, values were in general lower than in myxoedema (Table II) , but the ranges of values given by the two conditions show too great an overlap for the assay to be of much assistance in differentiating the two conditions.
In Cushing's Syndrome.-Owing to the rarity of this condition, very few cases showing the full syndrome have been available for study. In Precocious Puberty and Virilism.- Table IV shows the level of excretion in several cases of the adrenogenital syndrome. In all these cases oral cortisone therapy produced a lowering of 17-ketosteroid excretion.
In Thyrotoxicosis and Diabetes.-A number of patients were studied while suffering from one or both of these diseases, and, except when the two conditions were coincident, no systematic devia- tion from normal excretion values could be demonstrated. Of 32 patients suffering only from thyrotoxicosis, three cases had a 17-ketogenic steroid output above 20 mg./day (24, 24, and 30 mg.); in only one case was the 17-ketosteroid value abnormally high (female aged 30: 24 mg./ day; 17-ketogenic steroids 18 mg. / day).
The values found in diabetes and in coincident diabetes and thyrotoxicosis are shown in Fig. 3 . The high 17-ketogenic steroid levels found in the cases showing both conditions support the hypothesis of Hubble (1955) that hyperpituitarism is the underlying lesion in such cases.
In Amenorrhoea.-There were 33 cases of primary and secondary amenorrhoea in which no other endocrine disorder was obvious. Both the urinary oestrogen output and the urinary gonadotrophin output were low (oestrogen less than 15 i.u. / day and gonadotrophin less than 5 mouse-units/ day) in 13 cases: in one of these, aged 32, the output of 17-ketogenic steroids was 21 mg./day (17-ketosteroids 10 mg. /day) ; the values in the remaining cases were normal. Three patients had low urinary oestrogen outputs (below 15 i.u./day) and normal urinary gonadotrophin outputs (above 5 mouse-units/day): all had normal steroid excretions. The remaining 17 cases had normal urinary gonadotrophin outputs and normal urinary oestrogen outputs (20 to 160 i.u./day); the outputs of 17-ketogenic steroids showed rather a wide scatter, with a range of 2.5 to 22 mg./day, two being below and 14 being above the 80% limits.
In Gynaecomastia. The limits of the normal range are wide, so that a person's 17-ketogenic steroid excretion may vary considerably without reaching a value which would be regarded as abnormal. In this respect, the status of the 17-ketogenic steroid assay is similar to that of the 17-ketosteroid estimation. These observations emphasize the desirability of performing an adrenal function test wherever indicated. Thorn (1953) has discussed the application of stimulation of the adrenals by corticotrophin to the diagnosis of Addison's disease and of hypopituitarism, and Eik-Nes, Sandberg, Migeon, Tyler, and Samuels (1955) have shown that adrenal capacity can be estimated by following the level of plasma 17-hydroxycorticosteroids during corticotrophin stimulation. The results presented here and those of Hubble (1955) show that the 17-ketogenic steroid assay provides a satisfactory index of such stimulation, and moreover is much more suitable for routine use than the techniques of Eik-Nes et al. (1955) .
The very high values found in the patients with Xvirilizing adrenal hyperplasias are in accordance with the theory of Jailer (1953) , who postulated a block in the biosynthesis of compound F with consequent overproduction of the precursor, 17-hydroxyprogesterone. As this substance does not adequately suppress the pituitary production ot adrenocorticotrophic hormone, the effect is to produce adrenal hyperplasia, and although 17-hydroxyprogesterone is not in itself ketogenic it is probably converted in part to a 17-ketogenic steroid with a 17:20-diol side chain. In the cases of hirsutes cited, the 17-ketogenic steroid values were generally within the normal range, which accords with the common view that patients with hirsutes even with amenorrhoea are not usuallv suffering from adrenal virilism.
The potentialities of the 1 7-ketogenic steroid assay in diagnosis and control of treatment are best studied by comparison with the 17-ketosteroid assay. In most of the conditions considered, as far 17-KETOGENIC STEROIDS as single estimations are concerned, the two methods yield about the same amount of information as judged by the extent of the departure from normal. In suspected cases of the adrenogenital syndrome it is advantageous to have both assays performed, but in general it would seem that one would suffice. In view of the undoubted advantage of the 17-ketogenic steroid assay in following changes in adrenal function, as evidenced by corticotrophin tests, by treatment of cases of hypothyroidism (Hubble, 1955) , and by response to stress (Jepson, Jordan, and Levell, 1956) , this is the assay of choice.
The technique involves, of necessity, the estimation of 17-ketosteroids as a part of the 17-ketogenic steroid assay. Appleby,-Gibson, Norymberski, and Stubbs (1955) have recently elaborated a technique for assaying urinary corticosteroids based on the principle of the 17-ketogenic steroid assay but not involving an estimation of the 17-ketosteroids. The results obtained appear to be similar except in cases of the adrenogenital syndrome (Appleby et al., 1955) . This assay, embracing as it does, a larger group of adrenal steroids, may be more efficient than the assay used here for estimating adrenal function.
Summary
The normal range of urinary 17-ketogenic steroids has been established from assays on 182 persons aged from 3 to 101 years.
Values found in the following conditions are presented: Addison's disease, myxoedema, hypopituitarism, Cushing's syndrome, the adrenogenital syndrome, hirsutes, diabetes, thyrotoxicosis, amenorrhoea, rheumatoid arthritis, and obesity.
The relative utility of the 17-ketogenic steroid assay and the 17-ketosteroid assay is discussed, and the greater value of the former in corticotrophin tests is demonstrated
